干细胞移植治疗心肌梗死  

Stem Cells Transplantation for Myocardial Infarction

作　　者：许景涵[1] 王绍军[1] 

机构地区：[1]天津市第三中心医院,中国300170

出　　处：《华夏医药》2005年第4期313-314,共2页Hua-xia Medicine

摘　　要：目前对于心肌梗死的治疗，无论在疗效还是在适用性方面都存在一定缺陷。心肌梗死后心肌细胞和小血管的损失是一种难以逆转的病理改变，导致预后不良。由于干细胞具有可塑性，可分化为心肌细胞并导致新生血管形成，干细胞移植为治疗心肌梗死提供了一种新的方法。本文按所应用的干细胞种类，对此做一综述。Current therapies for myocardial infarction are limited in efficiency or in applicability.The loss of cardiomyocytes and little vessels is an irreversible pathological change and it can conduct unfavorable prognosis.Becanse stem cells can transdifferenate into cardiomyocytes and give rise to neovascularization by it＇s plasticity,stem cell transplantation offer a novel therapeutic approach for myocardial infarction.This article reviews the progress of it based on the types of stem cells applicated.

关 键 词：干细胞 移植 心肌梗死 

分 类 号：R542.22[医药卫生—心血管疾病]